Summer Heat Sinks Deal Making in July 2017

Deal makers took a break in July, judging by the lower deal volume and lower deal value posted in our preliminary data for the month. Compared with the previous month, deal volume dropped 20%, to 100 transactions, and deal value fell 49%, to $8.7 billion. Third quarters are typically slower for mergers and acquisitions, although there have been a few exceptions. In 2015, a record 411 deals were announced in Q3, which was 17% better than the same quarter in 2014, and 10% better than the third quarter in 2016. With little more than one month into Q3:17, we’ve logged 106 transactions. Not exactly a strong pace, but that could change. At this writing, the Senate Republicans failed to get the... Read More »

Summer Heat Sinks Deal Making in July

Deal makers took a break in July, judging by the lower deal volume and lower deal value posted in our preliminary data for the month. Compared with the previous month, deal volume dropped 20%, to 100 transactions, and deal value fell 49%, to $8.7 billion. Third quarters are typically slower for mergers and acquisitions, although there have been a few exceptions. In 2015, a record 411 deals were announced in Q3, which was 17% better than the same quarter in 2014, and 10% better than the third quarter in 2016. With little more than one month into Q3:17, we’ve logged 106 transactions. Not exactly a strong pace, but that could change. At this writing, the Senate Republicans failed to get the... Read More »

Follow the Funding, July 2017

This monthly feature focuses on various tranches and rounds of funding for healthcare ventures, startups and funds. Links indicate target companies and lead investors. TargetInvestorsAmountDate Theranics Bio-ElectronicsLightspeed Venture Partners, LionBird and Corundum Open Innovation$6 million, Series AJuly 3, 2017 Diasome Pharmaceuticals, Inc.Medicxi Ventures, JDRF T1D Fund, Black Beret Life Sciences, LLC and McDonald Partners, LLC$30 millionJuly 5, 2017 Omni Eye ServicesNew MainStream CapitalUndisclosedJuly 6, 2017 GenooxInimiti Capital Partners and Glilot Capital$6 millionJuly 11, 2017 Allurion TechnologiesRomulus Capital, with Cogepa Investments and IDO Investments$27 million, Series... Read More »